CLINICAL_TRIALS
trial_result
· 2019-08-06
Clinical Trial Update: Dose Range Finding Study of Bimagrumab in Sarcopenia [Phase 2]
Summary
Phase 2 dose range finding study of bimagrumab in sarcopenia completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Sarcopenia | Phase 2 | Status: COMPLETED | Results posted: 2019-08-06